Videos
Predicting Clinical Needs and Potential for Genetic Therapies in ALS: Jennifer Morganroth, MD, MBA
April 11th 2023At the 2023 MDA’s Clinical and Scientific conference, the neurology resident at Penn Medicine talked about the challenges of delivering intrathecal therapies and the importance of planning clinical resources for patients with ALS. [WATCH TIME: 3 minutes]
Diagnosis of Dyskinesia and Impact on Quality of Life of Patients With Parkinson Disease
The expert panel shares strategies for accurate clinical diagnosis of dyskinesia in patients with Parkinson disease and discusses how dyskinesia may impact the quality of life.
Risk Factors for Dyskinesia in Patients With Parkinson Disease
The expert neurology panel examines risk factors for development of dyskinesia in patients with Parkinson disease.
Timing of Treatment and Managing Attacks in MOGAD: Anastasia Vishnevetsky, MD
April 10th 2023The immunology fellow at Brigham and Women’s Hospital discussed the current state of care for patients with MOGAD, and whether treatment decisions differ based on timing of attacks. [WATCH TIME: 7 minutes]
Revolutionizing Treatment For Duchenne Muscular Dystrophy with Gene Editing: Courtney Young, PhD
April 10th 2023The co-founder and chief executive officer of MyoGene Bio talked about the advantages of gene editing over traditional gene therapy as a long term treatment for neuromuscular diseases at MDA’s 2023 conference. [WATCH TIME: 3 minutes]
Physical Therapy, Optimizing Function in Neuromuscular Diseases: Megan Iammarino, PT, DPT
April 9th 2023The research physical therapist at Nationwide Children’s Hospital talked about the role of physical therapy in the changing landscape of care with neuromuscular diseases at the 2023 MDA conference. [WATCH TIME: 5 minutes]
The Development of New Gene Therapies to Address Unmet Needs in ALS: Matthew B. Harms, MD
April 7th 2023The associate professor of neurology at Columbia University spoke at the 2023 MDA conference about the unmet needs of patients with ALS and the potential of new gene therapies. [WATCH TIME: 5 minutes]
Successes and Advances in Migraine Care Through Headache on the Hill: Julienne Verdi
April 6th 2023The executive director of the Alliance for Headache Disorders Advocacy discussed some of the successes from recent Headache on the Hills, and the expansion in centers of excellence for veterans with migraine. [WATCH TIME: 6 minutes]
Early Monitoring and Treatment for Bone Health in Duchenne Muscular Dystrophy: Meilan Rutter, MD
April 6th 2023At the 2023 MDA conference, a pediatric endocrinologist from Cincinnati Children’s Hospital talked about the unmet needs in treating bone health for patients with Duchenne muscular dystrophy. [WATCH TIME: 5 minutes]
Building a Greater Understanding for NMOSD Treatments, Neurodegeneration: John Chen, MD, PhD
April 5th 2023The neuroophtalmologist at Mayo Clinic detailed improvements in prescribing methods for NMOSD treatments and the conversations surrounding reversing neurodegeneration. [WATCH TIME: 3 minutes]
Personalized Treatment Approaches of Myopathies Based on Antibodies: Suur Bilicier, MD
April 5th 2023The associate professor of neurology at the University of Texas Health Science Center at Houston talked about advances in the classification of inflammatory myopathies at the recently concluded 2023 MDA conference. [WATCH TIME: 4 minutes]
Reasons for the Complex Diagnosis of Basilar Artery Occlusions: Russell Cerejo, MD
April 5th 2023The vascular neurologist at Allegheny Health Network provided perspective on the complex diagnosis of basilar artery occlusions and the signs clinicians and emergency room specialists should be aware of. [WATCH TIME: 2 minutes]
Pathophysiology of Dyskinesia in Parkinson Disease
Drs William G. Ondo and Robert A. Hauser discuss the understanding of pathophysiology and clinical features of dyskinesia in patients with Parkinson disease.
Challenges With Parkinson Disease Treatments
Drs Rajesh Pahwa and Daniel E. Kremens discuss challenges with Parkinson disease treatment and management of motor fluctuations, dyskinesia and OFF episodes in patients.
The Potential of Genetic Therapies in Neuromuscular Diseases: Stephan Züchner, MD, PhD
April 4th 2023At the 2023 MDA conference, the professor for human genetics and neurology at the University of Miami Miller School of Medicine talked about the role of genetics in neuromuscular diseases and potential therapies. [WATCH TIME: 5 minutes]
Lessons Learned and Future Possibilities in ALS Collaborations: Edritz Javelosa, PhD
April 4th 2023At the 2023 MDA conference, the scientific research portfolio director at Muscular Dystrophy Association detailed a session on collaborative research in ALS and ongoing efforts in the field. [WATCH TIME: 3 minutes]
